These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28238947)

  • 61. Prediction models for drug-induced hepatotoxicity by using weighted molecular fingerprints.
    Kim E; Nam H
    BMC Bioinformatics; 2017 May; 18(Suppl 7):227. PubMed ID: 28617228
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.
    Ming X; Knight BM; Thakker DR
    Mol Pharm; 2011 Oct; 8(5):1677-86. PubMed ID: 21780830
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Warner DJ; Chen H; Cantin LD; Kenna JG; Stahl S; Walker CL; Noeske T
    Drug Metab Dispos; 2012 Dec; 40(12):2332-41. PubMed ID: 22961681
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3.
    Oleschuk CJ; Deeley RG; Cole SP
    Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G280-9. PubMed ID: 12388190
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2).
    Hirohashi T; Suzuki H; Chu XY; Tamai I; Tsuji A; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Jan; 292(1):265-70. PubMed ID: 10604957
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure.
    Elsby R; Martin P; Surry D; Sharma P; Fenner K
    Drug Metab Dispos; 2016 Mar; 44(3):398-408. PubMed ID: 26700956
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Arsenic Triglutathione [As(GS)3] Transport by Multidrug Resistance Protein 1 (MRP1/ABCC1) Is Selectively Modified by Phosphorylation of Tyr920/Ser921 and Glycosylation of Asn19/Asn23.
    Shukalek CB; Swanlund DP; Rousseau RK; Weigl KE; Marensi V; Cole SP; Leslie EM
    Mol Pharmacol; 2016 Aug; 90(2):127-39. PubMed ID: 27297967
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors.
    Ritschel T; Hermans SM; Schreurs M; van den Heuvel JJ; Koenderink JB; Greupink R; Russel FG
    Chem Res Toxicol; 2014 May; 27(5):873-81. PubMed ID: 24713091
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening.
    Chen Y; Yuan X; Xiao Z; Jin H; Zhang L; Liu Z
    PLoS One; 2018; 13(10):e0205175. PubMed ID: 30321196
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.
    Sharma P; Holmes VE; Elsby R; Lambert C; Surry D
    Xenobiotica; 2010 Jan; 40(1):24-37. PubMed ID: 19919292
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
    El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
    Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Functional analysis of nonsynonymous single nucleotide polymorphism type ATP-binding cassette transmembrane transporter subfamily C member 3.
    Kobayashi K; Ito K; Takada T; Sugiyama Y; Suzuki H
    Pharmacogenet Genomics; 2008 Sep; 18(9):823-33. PubMed ID: 18698235
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mechanistic study on the intestinal absorption and disposition of baicalein.
    Zhang L; Lin G; Kovács B; Jani M; Krajcsi P; Zuo Z
    Eur J Pharm Sci; 2007 Jul; 31(3-4):221-31. PubMed ID: 17507208
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.
    Elsby R; Smith V; Fox L; Stresser D; Butters C; Sharma P; Surry DD
    Xenobiotica; 2011 Sep; 41(9):764-83. PubMed ID: 21612343
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
    Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
    Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
    [TBL] [Abstract][Full Text] [Related]  

  • 76. AI/ML Models to Predict the Severity of Drug-Induced Liver Injury for Small Molecules.
    Rao M; Nassiri V; Alhambra C; Snoeys J; Van Goethem F; Irrechukwu O; Aleo MD; Geys H; Mitra K; Will Y
    Chem Res Toxicol; 2023 Jul; 36(7):1129-1139. PubMed ID: 37294641
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).
    Zelcer N; Reid G; Wielinga P; Kuil A; van der Heijden I; Schuetz JD; Borst P
    Biochem J; 2003 Apr; 371(Pt 2):361-7. PubMed ID: 12523936
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.
    Muchova L; Vanova K; Suk J; Micuda S; Dolezelova E; Fuksa L; Cerny D; Farghali H; Zelenkova M; Lenicek M; Wong RJ; Vreman HJ; Vitek L
    J Cell Mol Med; 2015 May; 19(5):924-33. PubMed ID: 25683492
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of probe compound in MRP2 vesicular transport assays.
    Kidron H; Wissel G; Manevski N; Häkli M; Ketola RA; Finel M; Yliperttula M; Xhaard H; Urtti A
    Eur J Pharm Sci; 2012 May; 46(1-2):100-5. PubMed ID: 22406294
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins.
    Chen P; Zeng H; Wang Y; Fan X; Xu C; Deng R; Zhou X; Bi H; Huang M
    Drug Metab Dispos; 2014 May; 42(5):844-52. PubMed ID: 24510383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.